CG
NH

Cutler Group’s NantHealth, Inc NH Stock Holding History

Cutler Group’s Portfolio NH Stock Details NH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-13
Closed – – 6548
2020
Q4 		$0 Buy
+13
New +$489 ﹤0.01% 5721

Other funds holding NH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Cutler Group's NH Position: Q1 2021 in Review

Cutler Group sold out of NantHealth, Inc (NH) in Q1 2021, closing a stake of 13 shares.

Cutler Group first reported a position in NH in Q4 2020 and held it in 1 quarter. The position peaked at $0 in Q4 2020. 45 funds tracked by Wall St. Rank hold NH as of Q1 2021.

  • Cutler Group reported no remaining NantHealth, Inc position as of Q1 2021 after selling out during the quarter.
  • Cutler Group sold 13 NantHealth, Inc shares in Q1 2021.
  • Cutler Group first reported a position in NantHealth, Inc in Q4 2020 and held it in 1 quarter.
  • Cutler Group's NantHealth, Inc position peaked at $0 in Q4 2020.
  • 45 funds tracked by Wall St. Rank held NantHealth, Inc as of Q1 2021.

Based on Cutler Group's 13F filing for Q1 2021, filed 26 Apr 2021.